Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

Key opinion leaders and company management will discuss the current spinal cord injury treatment landscape and NervGen's ...

International private equity firm Cinven has completed its previously announced sale of an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, ...

The country's top specialty generics company recently acquired US-based Checkpoint that will further its oncology portfolio ...

A comprehensive assessment reveals that Sri Lanka’s pharmaceutical supply chain, though grounded in strong public access, ...

Too often, the disconnect between a company’s IT department and its business teams slows progress and leads to missed ...

It takes courage for a business to pivot – especially a publicly listed one answerable to shareholders – but biotech Clever ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Charles River Laboratories International, Inc.

Bank of New York Mellon Corp lifted its holdings in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 271.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 82 ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...